Patents by Inventor Mark T. Barrila

Mark T. Barrila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6696574
    Abstract: The instant invention provides novel processes and intermediates useful in the preparation of certain N-(indole-2-carbonyl)-&bgr;-alaninamide compounds, which compounds are glycogen phosphorylase inhibitors useful in the treatment of diseases such as hypercholesterolemia, hyperglycemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis, diabetes, diabetic cardiomyopathy, infection, tissue ischemia, myocardial ischemia, and in inhibiting tumor growth.
    Type: Grant
    Filed: January 16, 2003
    Date of Patent: February 24, 2004
    Assignee: Pfizer Inc.
    Inventors: Mark T. Barrila, Frank R. Busch, Michel A. Couturier, Susan L. Orrill, Peter R. Rose, Derek L. Tickner, Harry O. Tobiassen, Gregory J. Withbroe
  • Publication number: 20030187051
    Abstract: The instant invention provides novel processes and intermediates useful in the preparation of certain N-(indole-2-carbonyl)-&bgr;-alaninamide compounds, which compounds are glycogen phosphorylase inhibitors useful in the treatment of diseases such as hypercholesterolemia, hyperglycemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis, diabetes, diabetic cardiomyopathy, infection, tissue ischemia, myocardial ischemia, and in inhibiting tumor growth.
    Type: Application
    Filed: January 16, 2003
    Publication date: October 2, 2003
    Applicant: Pfizer Inc.
    Inventors: Mark T. Barrila, Frank R. Busch, Michel A. Couturier, Susan L. Orrill, Peter R. Rose, Derek L. Tickner, Harry O Tobiassen, Gregory J. Withbroe